nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.0551	0.0551	CbGpPWpGaD
Ergonovine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RASGRP1—Crohn's disease	0.0299	0.0299	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0244	0.0244	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0209	0.0209	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0198	0.0198	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—CCR9—Crohn's disease	0.0172	0.0172	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.016	0.016	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—ACKR2—Crohn's disease	0.0159	0.0159	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—MLN—Crohn's disease	0.0151	0.0151	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—MLN—Crohn's disease	0.015	0.015	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.0149	0.0149	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0137	0.0137	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.0134	0.0134	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—MLN—Crohn's disease	0.0128	0.0128	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0127	0.0127	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.0124	0.0124	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0123	0.0123	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.0114	0.0114	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—CCR6—Crohn's disease	0.0114	0.0114	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.0106	0.0106	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0105	0.0105	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CCR9—Crohn's disease	0.0104	0.0104	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0104	0.0104	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00995	0.00995	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—GPR65—Crohn's disease	0.00971	0.00971	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—GPR65—Crohn's disease	0.00968	0.00968	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00933	0.00933	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00908	0.00908	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00892	0.00892	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00866	0.00866	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—MLN—Crohn's disease	0.00851	0.00851	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00846	0.00846	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—GPR65—Crohn's disease	0.00823	0.00823	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—ACKR2—Crohn's disease	0.00815	0.00815	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00805	0.00805	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.008	0.008	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—ACKR2—Crohn's disease	0.00799	0.00799	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—MLN—Crohn's disease	0.00773	0.00773	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—MLN—Crohn's disease	0.00758	0.00758	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00748	0.00748	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00736	0.00736	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CCR6—Crohn's disease	0.00692	0.00692	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0069	0.0069	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00686	0.00686	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00684	0.00684	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—ACKR2—Crohn's disease	0.0068	0.0068	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.00651	0.00651	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—MLN—Crohn's disease	0.00644	0.00644	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00641	0.00641	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00636	0.00636	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—PTGER4—Crohn's disease	0.00609	0.00609	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.00605	0.00605	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CCR9—Crohn's disease	0.0059	0.0059	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00586	0.00586	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—GPR65—Crohn's disease	0.00549	0.00549	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00545	0.00545	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCR9—Crohn's disease	0.00536	0.00536	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00533	0.00533	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCR9—Crohn's disease	0.00525	0.00525	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.005	0.005	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—GPR65—Crohn's disease	0.00498	0.00498	CbGpPWpGaD
Ergonovine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.00492	0.00492	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—GPR65—Crohn's disease	0.00488	0.00488	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ACKR2—Crohn's disease	0.00482	0.00482	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00469	0.00469	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00457	0.00457	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MLN—Crohn's disease	0.00457	0.00457	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00453	0.00453	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00447	0.00447	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCR9—Crohn's disease	0.00447	0.00447	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.00443	0.00443	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—MLN—Crohn's disease	0.00428	0.00428	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00425	0.00425	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TAGAP—Crohn's disease	0.00418	0.00418	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—GPR65—Crohn's disease	0.00415	0.00415	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—ACKR2—Crohn's disease	0.0041	0.0041	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00402	0.00402	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00399	0.00399	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.00394	0.00394	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CCR6—Crohn's disease	0.00391	0.00391	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MLN—Crohn's disease	0.00389	0.00389	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00388	0.00388	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00381	0.00381	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00368	0.00368	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—RSPO3—Crohn's disease	0.00365	0.00365	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—MLN—Crohn's disease	0.00364	0.00364	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCR6—Crohn's disease	0.00355	0.00355	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—ACKR2—Crohn's disease	0.00349	0.00349	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCR6—Crohn's disease	0.00348	0.00348	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SEL1L—Crohn's disease	0.00346	0.00346	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—PTGER4—Crohn's disease	0.00344	0.00344	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00342	0.00342	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MLN—Crohn's disease	0.00331	0.00331	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCR9—Crohn's disease	0.00317	0.00317	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—PTGER4—Crohn's disease	0.00312	0.00312	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—PTGER4—Crohn's disease	0.00306	0.00306	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.00303	0.00303	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCR9—Crohn's disease	0.00297	0.00297	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCR6—Crohn's disease	0.00296	0.00296	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—GPR65—Crohn's disease	0.00294	0.00294	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—IL3—Crohn's disease	0.00293	0.00293	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00293	0.00293	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00283	0.00283	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.00278	0.00278	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—GPR65—Crohn's disease	0.00276	0.00276	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCR9—Crohn's disease	0.0027	0.0027	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL3—Crohn's disease	0.00266	0.00266	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—PTGER4—Crohn's disease	0.0026	0.0026	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.0026	0.0026	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—RASGRP1—Crohn's disease	0.00257	0.00257	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCR9—Crohn's disease	0.00252	0.00252	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—GPR65—Crohn's disease	0.00251	0.00251	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00249	0.00249	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00249	0.00249	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ACKR2—Crohn's disease	0.00242	0.00242	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.00242	0.00242	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—GPR65—Crohn's disease	0.00235	0.00235	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.00232	0.00232	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MLN—Crohn's disease	0.0023	0.0023	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCR9—Crohn's disease	0.00229	0.00229	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00228	0.00228	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CXCL8—Crohn's disease	0.00223	0.00223	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00218	0.00218	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—GPR65—Crohn's disease	0.00213	0.00213	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TAGAP—Crohn's disease	0.0021	0.0021	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCR6—Crohn's disease	0.0021	0.0021	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ACKR2—Crohn's disease	0.00206	0.00206	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—IL2RA—Crohn's disease	0.00205	0.00205	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCR6—Crohn's disease	0.00197	0.00197	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MLN—Crohn's disease	0.00195	0.00195	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00194	0.00194	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—RBX1—Crohn's disease	0.0019	0.0019	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL2RA—Crohn's disease	0.00186	0.00186	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00185	0.00185	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PTGER4—Crohn's disease	0.00185	0.00185	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RSPO3—Crohn's disease	0.00184	0.00184	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	0.00179	0.00179	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCR6—Crohn's disease	0.00179	0.00179	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00176	0.00176	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SEL1L—Crohn's disease	0.00174	0.00174	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PTGER4—Crohn's disease	0.00173	0.00173	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.00168	0.00168	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	0.00167	0.00167	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—UBE2D1—Crohn's disease	0.00166	0.00166	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—RIPK2—Crohn's disease	0.00161	0.00161	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCR9—Crohn's disease	0.00159	0.00159	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL3—Crohn's disease	0.00157	0.00157	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PTGER4—Crohn's disease	0.00157	0.00157	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	0.00156	0.00156	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00155	0.00155	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—RASGRP1—Crohn's disease	0.00152	0.00152	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	0.00152	0.00152	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	0.00148	0.00148	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GPR65—Crohn's disease	0.00148	0.00148	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—IL3—Crohn's disease	0.00147	0.00147	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00147	0.00147	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	0.00147	0.00147	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00143	0.00143	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—JAK2—Crohn's disease	0.00138	0.00138	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SOCS1—Crohn's disease	0.00138	0.00138	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.00137	0.00137	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	0.00135	0.00135	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL3—Crohn's disease	0.00134	0.00134	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	0.00134	0.00134	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—TYK2—Crohn's disease	0.00131	0.00131	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—RASGRP1—Crohn's disease	0.00129	0.00129	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CXCL8—Crohn's disease	0.00126	0.00126	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	0.00126	0.00126	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—JAK2—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.00123	0.00123	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00121	0.00121	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SMAD3—Crohn's disease	0.00119	0.00119	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTMR3—Crohn's disease	0.00117	0.00117	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CXCL8—Crohn's disease	0.00114	0.00114	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	0.00114	0.00114	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CXCL8—Crohn's disease	0.00112	0.00112	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.00112	0.00112	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL2RA—Crohn's disease	0.0011	0.0011	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.0011	0.0011	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCR6—Crohn's disease	0.00105	0.00105	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	0.00103	0.00103	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RBX1—Crohn's disease	0.000954	0.000954	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000953	0.000953	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.00095	0.00095	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	0.000938	0.000938	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	0.000929	0.000929	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—FADS1—Crohn's disease	0.000909	0.000909	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	0.000897	0.000897	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000878	0.000878	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GPX4—Crohn's disease	0.000851	0.000851	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	0.000846	0.000846	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	0.000836	0.000836	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000831	0.000831	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GCKR—Crohn's disease	0.000822	0.000822	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	0.000811	0.000811	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	0.000811	0.000811	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000797	0.000797	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL3—Crohn's disease	0.000791	0.000791	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	0.00079	0.00079	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TYK2—Crohn's disease	0.000776	0.000776	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	0.000765	0.000765	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—JAK2—Crohn's disease	0.00074	0.00074	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000719	0.000719	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000711	0.000711	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	0.000694	0.000694	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	0.000693	0.000693	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	0.00069	0.00069	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCL8—Crohn's disease	0.000676	0.000676	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	0.000673	0.000673	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	0.000661	0.000661	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	0.00065	0.00065	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—Crohn's disease	0.000642	0.000642	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	0.000634	0.000634	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	0.00063	0.00063	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	0.000598	0.000598	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	0.00059	0.00059	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	0.000589	0.000589	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	0.000575	0.000575	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	0.000562	0.000562	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—FADS1—Crohn's disease	0.00056	0.00056	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000559	0.000559	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	0.000554	0.000554	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STAT3—Crohn's disease	0.000543	0.000543	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000539	0.000539	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	0.000536	0.000536	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX4—Crohn's disease	0.000525	0.000525	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	0.000509	0.000509	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GCKR—Crohn's disease	0.000507	0.000507	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	0.000489	0.000489	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	0.000471	0.000471	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	0.00039	0.00039	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—Crohn's disease	0.00038	0.00038	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	0.000372	0.000372	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	0.00034	0.00034	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	0.000332	0.000332	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	0.000323	0.000323	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	0.000317	0.000317	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	0.000289	0.000289	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	0.000275	0.000275	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	0.000273	0.000273	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALB—Crohn's disease	0.000262	0.000262	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	0.000232	0.000232	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTGS2—Crohn's disease	0.000229	0.000229	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—Crohn's disease	0.000191	0.000191	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	0.000162	0.000162	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALB—Crohn's disease	0.000161	0.000161	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTGS2—Crohn's disease	0.000141	0.000141	CbGpPWpGaD
